Skip to main content

Table 1 Patient characteristics, primary cancer, and intraperitoneal chemotherapy

From: Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience

Age; years

52 (20–72)

Gender; Male:Female

23:34

Weight; kg / Height; cm

70 (44–112) / 168 (155–185)

BMI; kg m−2

25 (16–41)

ASA class I/II/III

5/49/3

Comorbidities 1

 

Cardiovascular

14

Pulmonary

5

Renal

4

Endocrine

3

Neurological

4

Obesity (BMI >30)

8

Medication

 

Single ß-blocking agent

2

Single ACE-inhibitor/AT2-blocker

3

Single diuretic

0

Combination of at least two drugs

6

Other drugs2

27

None

23

Origin of primary cancer

 

Appendix

33

Ovary

1

Colorectal

13

Mesothelioma

5

Gastric

1

Other origin3

4

  1. 54 patients underwent 57 procedures. Data are expressed as median (range) and numbers.
  2. ACE, angiotensin converting enzyme; ASA, American Society of Anesthesiology; AT2, angiotensin II; BMI, body mass index (kg m−2).
  3. 1Comorbidities: cardiovascular (arterial hypertension, cardiac valve pathology, hyperlipidemia); pulmonary (chronic bronchitis, asthma, obstructive sleep apnea syndrome, history of acute respiratory distress syndrome, history of pulmonary embolism); renal (one sided kidney agenesia, history of carcinoma of the kidney, incidentaloma, chronic kidney disease); endocrine (previous ovariectomy, medically treated hypothyroidism, diabetes mellitus); neurological (polyneuropathy, paraesthesia, migraine, herniated vertebral disc with neurological symptoms).
  4. 2Twenty seven patients were on additional medication: analgesics (n = 9), proton pump inhibitors (n = 6), vitamins and supplements (n = 5), laxatives (n = 5), hormone replacement therapy (n = 5), sedatives (n = 3), oral antidiabetics (n = 1), chemotherapeutic agents (n = 1), antidepressants (n = 1), antidiarrheals (n = 1), antiemetics (n = 1), acetylsalicylic acid (n = 1), statins (n = 1), calcium channel blocker (n = 1), herbal and homeopathic preparations (n = 2).
  5. 3Other origin summarizes endometrioid cancer (n = 2), cancer of the small intestine (n = 1) and urachus cancer (n = 1).